Rituximab ameliorated severe hearing loss in Cogan's syndrome: A case report

Orphanet Journal of Rare Diseases

Volumn 5, Issue 1, 2010, Pages

  Orsoni, Jelka G ^a   Laganà, Bruno ^b   Rubino, Pierangela ^a   Zavota, Laura ^a   Bacciu, Salvatore ^a   Mora, Paolo ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; METHOTREXATE; PREDNISONE; RITUXIMAB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; AUDIOMETRY; CASE REPORT; COGAN SYNDROME; CONJUNCTIVAL HYPEREMIA; DISEASE SEVERITY; FEMALE; HEARING LOSS; HUMAN; LYMPHOCYTE COUNT; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS;

ADULT; ANTIBODIES, MONOCLONAL; COGAN SYNDROME; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS;

EID: 77953512318     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-5-18     Document Type: Article

References (12)

1. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59. J Golay M Lazzari V Facchinetti S Bernasconi G Borleri T Barbui A Rambaldi M Introna, Blood 2001 98 3383 3389 10.1182/blood.V98.12.3383 11719378
2. Anti-68 kDa antibodies in autoimmune sensorineural hearing loss: are these autoantibodies really a diagnostic tool? C Bonaguri JG Orsoni L Zavota C Monica A Russo I Pellistri P Rubino L Goivannelli F Manzotti F Piazza, Autoimmunity 2007 40 73 78 10.1080/08916930601119377 17364500
3. Discontinuous drug combination therapy in autoimmune ocular disorders. JG Orsoni L Zavota P Mora P Rubino F Manzotti I Pellistri, Acta Ophthalmol 2009 87 340 345 10.1111/j.1755-3768.2008.01256.x 18785963
4. Atypical Cogan's syndrome: an autoimmune disease? GJ Peeters CW Cremers AJ Pinckers WH Hoefnagel, Ann Otol Rhinol Laryngol 1986 95 173 175 3963689
5. Cogan's syndrome: present and future directions. G Murphy MO Sullivan F Shanahan S Harney M Molloy, Reumathol Int 2009 29 1117 1121 10.1007/s00296-009- 0945-0
6. Cogan's syndrome: an audiovestibular, ocular, and systemic autoimmune disease. M Mazlumzadeh EL Matteson, Rheum Dis Clin North Am 2007 33 855 874 10.1016/j.rdc.2007.07.015 18037121
7. Mycophenolate mofetil as a treatment of steroid dependent Cogan's syndrome in childhood. C Hautefort N Loundon M Montchilova S Marlin EN Garabedian T Ulinski, Int J Pediatr Otorhinolaringol 2009
8. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. EL Matteson HK Choi DS Poe C Wise VJ Lowe TJ McDonald MU Rahman, Arthritis Rheum 2005 53 337 342 10.1002/art.21179 15934127
9. A novel therapeutic option in Cogan diseases? TNF-a blockers. M Fricker F Baumann F Wermelinger PM Villiger A Helbling, Rheumatol Int 2007 27 493 495 10.1007/s00296-006-0252-y 17102947
10. Efficacy of Infliximab in Cogan's Syndrome. R Ghadban M Couret T Zenone, J Rheumatol 2008 35 2456 2458 10.3899/jrheum.080203 19143047
11. Rituximab therapy in primary Sjögren's syndrome. C Alcntara MJ Gomes C Ferreira, Ann N Y Acad Sci 2009 1173 701 705 10.1111/j.1749-6632.2009.04639.x 19758218
12. Churg-Strauss syndrome successfully treated with rituximab. KK Dønvik R Omdal, Rheumatol Int 2009